Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1683
    +0.0027 (+0.23%)
     
  • GBP/USD

    1.2493
    -0.0018 (-0.14%)
     
  • Bitcoin GBP

    51,188.80
    -627.98 (-1.21%)
     
  • CMC Crypto 200

    1,333.31
    -63.22 (-4.53%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.65
    +0.08 (+0.10%)
     
  • GOLD FUTURES

    2,350.50
    +8.00 (+0.34%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Analysts Have Just Cut Their uniQure N.V. (NASDAQ:QURE) Revenue Estimates By 16%

Market forces rained on the parade of uniQure N.V. (NASDAQ:QURE) shareholders today, when the analysts downgraded their forecasts for this year. This report focused on revenue estimates, and it looks as though the consensus view of the business has become substantially more conservative.

Following the latest downgrade, the current consensus, from the 16 analysts covering uniQure, is for revenues of US$2.2m in 2020, which would reflect a concerning 65% reduction in uniQure's sales over the past 12 months. Per-share losses are expected to creep up to US$3.12. However, before this estimates update, the consensus had been expecting revenues of US$2.6m and US$3.11 per share in losses. So there's been quite a change-up of views after the recent consensus updates, with the analysts making a serious cut to their revenue forecasts while also making no real change to the loss per share numbers.

View our latest analysis for uniQure

NasdaqGS:QURE Past and Future Earnings May 18th 2020
NasdaqGS:QURE Past and Future Earnings May 18th 2020

The consensus price target was broadly unchanged at €79.18, implying that the business is performing roughly in line with expectations, despite a downwards adjustment to forecast sales this year. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic uniQure analyst has a price target of €94.19 per share, while the most pessimistic values it at €67.25. There are definitely some different views on the stock, but the range of estimates is not wide enough as to imply that the situation is unforecastable, in our view.

ADVERTISEMENT

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. One more thing stood out to us about these estimates, and it's the idea that uniQure'sdecline is expected to accelerate, with revenues forecast to fall 65% next year, topping off a historical decline of 6.5% a year over the past five years. Compare this against analyst estimates for companies in the wider industry, which suggest that revenues (in aggregate) are expected to grow 24% next year. So it's pretty clear that, while it does have declining revenues, the analysts also expect uniQure to suffer worse than the wider industry.

The Bottom Line

Unfortunately analysts also downgraded their revenue estimates, and industry data suggests that uniQure's revenues are expected to grow slower than the wider market. Given the stark change in sentiment, we'd understand if investors became more cautious on uniQure after today.

Even so, the longer term trajectory of the business is much more important for the value creation of shareholders. At Simply Wall St, we have a full range of analyst estimates for uniQure going out to 2024, and you can see them free on our platform here.

Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are downgrading their estimates. So you may also wish to search this free list of stocks that insiders are buying.

Love or hate this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Thank you for reading.